Jefferies Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,131
Closed -$259K 1923
2022
Q1
$259K Buy
+4,131
New +$223K ﹤0.01% 1216
2020
Q3
Sell
-1,230
Closed -$43 1595
2020
Q2
$43 Buy
1,230
+765
+165% +$26.3K ﹤0.01% 1164
2020
Q1
$12K Buy
+465
New +$13.8K ﹤0.01% 1960

Other funds holding AXNX

Jefferies Group's AXNX Position: Q2 2022 in Review

Jefferies Group sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 4,131 shares — an estimated $259K sold.

Jefferies Group first reported a position in AXNX in Q1 2020 and held it in 3 quarters. The position peaked at $259K in Q1 2022. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

  • Jefferies Group reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 4,131 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $259K.
  • Jefferies Group first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Jefferies Group's Axonics, Inc. Common Stock position peaked at $259K in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.